Ambu A/S (OTCMKTS:AMBBY) Shares Gap Down - Time to Sell?

Key Points

• Gap down: shares opened at $10.60 after closing at $11.11 and were trading down about 4.6% on light volume (514 shares), signaling immediate selling pressure.
• Technical/valuation: the stock sits below its 50‑day ($12.83) and 200‑day ($13.96) moving averages and has a market cap of $2.49 billion with a PE of 34.19, indicating relative technical weakness and a premium valuation.
• Recent results and financials: Ambu reported Q results of EPS $0.07 on $242.85 million revenue, with a net margin of 8.86%, return on equity 9.15%, strong liquidity (current ratio 2.86, quick ratio 1.67) and low leverage (debt/equity 0.08).

Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY - Get Free Report)'s stock price gapped down before the market opened on Friday . The stock had previously closed at $11.11, but opened at $10.60. Ambu A/S shares last traded at $10.60, with a volume of 514 shares trading hands.

Ambu A/S Trading Down 4.6%

The firm has a 50-day moving average price of $12.83 and a 200-day moving average price of $13.96. The stock has a market cap of $2.49 billion, a PE ratio of 34.19 and a beta of 0.98. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.67 and a current ratio of 2.86.

Ambu A/S (OTCMKTS:AMBBY - Get Free Report) last issued its earnings results on Wednesday, February 4th. The company reported $0.07 EPS for the quarter. Ambu A/S had a return on equity of 9.15% and a net margin of 8.86%.The business had revenue of $242.85 million for the quarter.

Ambu A/S Company Profile

Ambu A/S is a Denmark-based medical device company specializing in single-use diagnostic and life-supporting equipment for hospitals, clinics and emergency services. The company's core focus lies in developing products that enhance patient safety, streamline clinical workflows and reduce the risk of cross-contamination. Ambu's offerings span critical care solutions such as anesthesia and respiratory care devices, as well as advanced endoscopy systems for minimally invasive diagnostics and therapies.

Within its anesthesia and respiratory care segment, Ambu is known for its market-leading disposable resuscitators—commonly referred to as “Ambu bags”—as well as a range of airway management products, including laryngeal masks and endotracheal tubes.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.